
MBX Biosciences, Inc.
MBXNasdaqCIK 1776111HealthcareFiscal year ends Dec 31
Reports and events: 56 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-09-2316:34 ET | SC 13D | Ownership report, active investor | 0000947871-24-000767 |
| 2024-09-2310:48 ET | SC 13D | Ownership report, active investor | 0001193125-24-223402 |
| 2024-09-1616:21 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-219621 |
| 2024-09-0906:06 ET | S-1/A | Registration statement, amended | 0001193125-24-215436 |
| 2024-08-3017:13 ET | S-1/A | Registration statement, amended | 0001193125-24-211217 |
| 2024-08-2316:44 ET | S-1 | Registration statement | 0001193125-24-206227 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 18:07 ET. Listed shows no prices and gives no investment advice.